Stock Events

22nd Century 

$0.67
122
-$0.04-5.64% Friday 19:51

Statistics

Day High
-
Day Low
0.67
52W High
110.24
52W Low
0.58
Volume
80,673
Avg. Volume
752,576
Mkt Cap
5.56M
P/E Ratio
0
Dividend Yield
-
Dividend
-

Earnings

15MayConfirmed
Q3 2022
Q4 2022
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
-10.56
-7.06
-3.56
-0.06
Expected EPS
-8.64
Actual EPS
-1.72

People Also Follow

This list is based on the watchlists of people on Stock Events who follow XXII. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Miscellaneous
Health Technology
Biotechnology
Manufacturing
Tobacco Manufacturing
22nd Century Group, Inc., an agricultural biotechnology company, focuses on tobacco harm reduction, reduced nicotine tobacco, and enhancing health and wellness through plant science for the life science and consumer products industries. It develops very low nicotine content tobacco and cigarette products under the VLN King and VLN Menthol King names; and SPECTRUM research cigarettes for use in independent clinical studies. The company has collaboration with Keygene N.V. to develop hemp/cannabis plants for exceptional cannabinoid profiles and other superior agronomic traits for medical, therapeutic, and agricultural uses, as well as other applications. 22nd Century Group, Inc. was founded in 1998 and is headquartered in Buffalo, New York.
Show more...
CEO
Employees
64
Country
US
ISIN
US90137F1030

Listings